Study to Evaluate the Efficacy of Poppi Apple Cider Vinegar Prebiotic Soda to Improve Gut Health In Participants

NCT05418439 | Completed

• 1 other identifier: 20229 Poppi
• Study Type: interventional
• Target: 38
• Locations: 1 country
• Sites: 1

Brief Summary

This exploratory observational trial provides the opportunity to gather information on the effect of daily consumption of Poppi Apple Cider Vinegar Prebiotic Soda on gut health and digestion.

Conditions

IBS - Irritable Bowel Syndrome

Keywords

bloating; abdominal pain; gassiness; heartburn

Outcome Measures

Primary Outcomes (3)

• Change in IBS symptoms [Time Frame: Baseline to 4 weeks)

  Survey-based assessment (0-5 scale) of changes in IBS symptoms with higher scores representing an improved outcome.

  4 weeks

• Change in bowel movements [Time Frame: Baseline to 4 weeks)

  Survey-based assessment (0-5 scale) of changes in stool frequency and consistency (constipation vs. diarrhea vs. normal) with higher scores representing an improved outcome.

  4 weeks

• Change in skin health [Time Frame: Baseline to 4 weeks)

  Survey-based assessment (0-5 scale) of changes in perceived skin health with higher scores representing an improved outcome.

  4 weeks

Study Arms (1)

Poppi ACV prebiotic soda

EXPERIMENTAL

Each day in the morning, for lunch, or in the afternoon, participants will drink one 12 fl oz. can of Poppi ACV prebiotic soda.

Dietary Supplement: Drink Poppi Soda

Interventions

Drink Poppi Soda DIETARY_SUPPLEMENT

Drink Poppi Vinager Soda

Poppi ACV prebiotic soda

Eligibility Criteria

• Age: 18 Years - 45 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Age: 18-45
• Male or Female
• Must be in generally good health
• BMI under 35
• Self-reported issues with gas, bloating, heartburn/acid reflux, abdominal pain or digestion
• Willing to maintain their standard dietary pattern, activity level and body weight for the duration of the study

You may not qualify if:

• Severe chronic conditions, including oncological conditions or psychiatric disease
• Currently pregnant, wanting to become pregnant, or breastfeeding for the duration of the study
• Taking any prescription medication targeting the gut
• Taking any supplements targeting the gut in the past month
• Use of antibiotics in the past 3 months

Sponsors & Collaborators

• Drink Poppi: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome; Abdominal Pain; Heartburn

Condition Hierarchy (Ancestors)

Colonic Diseases, Functional; Colonic Diseases; Intestinal Diseases; Gastrointestinal Diseases; Digestive System Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Signs and Symptoms, Digestive

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 10, 2022
• First Posted: June 14, 2022
• Study Start: April 1, 2022
• Primary Completion: May 1, 2022
• Study Completion: May 1, 2022
• Last Updated: June 15, 2022

Record last verified: 2022-06

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)